Cargando…

Lung-heart toxicity in a randomized clinical trial of hypofractionated image guided radiation therapy for breast cancer

BACKGROUND: TomoBreast hypothesized that hypofractionated 15 fractions/3 weeks image-guided radiation therapy (H-IGRT) can reduce lung-heart toxicity, as compared with normofractionated 25-33 fractions/5-7 weeks conventional radiation therapy (CRT). METHODS: In a single center 123 women with stage I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Parijs, Hilde, Cecilia-Joseph, Elsa, Gorobets, Olena, Storme, Guy, Adriaenssens, Nele, Heyndrickx, Benedicte, Verschraegen, Claire, Nguyen, Nam P., De Ridder, Mark, Vinh-Hung, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694354/ http://dx.doi.org/10.3389/fonc.2023.1211544

Ejemplares similares

Cardiopulmonary-related patient-reported outcomes in a randomized clinical trial of radiation therapy for breast cancer
por: Van Parijs, Hilde, et al.
Publicado: (2021)

Lung-Heart Outcomes and Mortality through the 2020 COVID-19 Pandemic in a Prospective Cohort of Breast Cancer Radiotherapy Patients
por: Vinh-Hung, Vincent, et al.
Publicado: (2022)

Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy
por: Versmessen, Harijati, et al.
Publicado: (2012)

Early Contralateral Shoulder-Arm Morbidity in Breast Cancer Patients Enrolled in a Randomized Trial of Post-Surgery Radiation Therapy
por: Adriaenssens, Nele, et al.
Publicado: (2012)

Two-Level Factorial Pre-TomoBreast Pilot Study of Tomotherapy and Conventional Radiotherapy in Breast Cancer: Post Hoc Utility of a Mean Absolute Dose Deviation Penalty Score
por: Heymann, Steve, et al.
Publicado: (2020)

Scapula alata in early breast cancer patients enrolled in a randomized clinical trial of post-surgery short-course image-guided radiotherapy
por: Adriaenssens, Nele, et al.
Publicado: (2012)

Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial
por: Van Parijs, Hilde, et al.
Publicado: (2012)

Axillary Lymph Node Involvement in Breast Cancer: A Random Walk Model of Tumor Burden
por: Vinh-Hung, Vincent, et al.
Publicado: (2019)

Gini's mean difference and the long-term prognostic value of nodal quanta classes after pre-operative chemotherapy in advanced breast cancer
por: Vinh-Hung, Vincent, et al.
Publicado: (2022)

Is there utility for fluorine-18-fluorodeoxyglucose positron-emission tomography scan before surgery in breast cancer? A 15-year overall survival analysis
por: Perrin, Justine, et al.
Publicado: (2022)

A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients
por: Norkus, Darius, et al.
Publicado: (2013)

Breast Conserving Treatment for Breast Cancer: Dosimetric Comparison of Sequential versus Simultaneous Integrated Photon Boost
por: Van Parijs, Hilde, et al.
Publicado: (2014)

Breast conserving treatment for breast cancer: dosimetric comparison of different non-invasive techniques for additional boost delivery
por: Van Parijs, Hilde, et al.
Publicado: (2014)

Lymph Node Ratio after Neoadjuvant Chemotherapy for Stage II/III Breast Cancer: Prognostic Value Measured with Gini’s Mean Difference of Restricted Mean Survival Times
por: Keam, Bhumsuk, et al.
Publicado: (2021)

Prognostic value of histopathology and trends in cervical cancer: a SEER population study
por: Vinh-Hung, Vincent, et al.
Publicado: (2007)

Ratios of involved nodes in early breast cancer
por: Vinh-Hung, Vincent, et al.
Publicado: (2004)

Normal tissue toxicity after small field hypofractionated stereotactic body radiation
por: Milano, Michael T, et al.
Publicado: (2008)

Toxicity and Outcomes of Moderately Hypofractionated Radiation for Prostate Cancer With Seminal Vesicle Involvement
por: Acklin-Wehnert, Scarlett, et al.
Publicado: (2023)

Immunotherapy and Hypofractionated Radiotherapy in Older Patients with Locally Advanced Cutaneous Squamous-Cell Carcinoma of the Head and Neck: A Proposed Paradigm by the International Geriatric Radiotherapy Group
por: Nguyen, Nam P., et al.
Publicado: (2023)

Hypofractionated Postmastectomy Radiation Therapy
por: Sayan, Mutlay, et al.
Publicado: (2020)

Outcome and toxicity of hypofractionated image-guided SABR for spinal oligometastases
por: Billiet, Charlotte, et al.
Publicado: (2020)

Image-Guided Radiotherapy for Locally Advanced Head and Neck Cancer
por: Nguyen, Nam P., et al.
Publicado: (2013)

Outcomes and toxicity from a prospective study of moderately hypofractionated radiation therapy for prostate cancer
por: Wang, Wei Gang, et al.
Publicado: (2017)

Hypofractionated Radiation Therapy for Large Brain Metastases
por: Masucci, Giuseppina Laura
Publicado: (2018)

Effect of Large Prostate Volume on Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy in Patients With Prostate Cancer
por: Natesan, Divya, et al.
Publicado: (2021)

Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial
por: Beaudry, M.M., et al.
Publicado: (2023)

Preoperative [18]fluorodeoxyglucose-positron emission tomography/computed tomography in early stage breast cancer: Rates of distant metastases
por: Vinh-Hung, Vincent, et al.
Publicado: (2017)

Is prone free breathing better than supine deep inspiration breath-hold for left whole-breast radiotherapy? A dosimetric analysis
por: Wang, Xinzhuo, et al.
Publicado: (2021)

Prone versus supine free-breathing for right-sided whole breast radiotherapy
por: Fargier-Bochaton, Odile, et al.
Publicado: (2022)

A Comprehensive Prospective Comparison of Acute Skin Toxicity after Hypofractionated and Normofractionated Radiation Therapy in Breast Cancer
por: Borm, Kai J., et al.
Publicado: (2021)

Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
por: Lewitzki, Victor, et al.
Publicado: (2015)

Mild Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
por: Matsui, Toshiaki, et al.
Publicado: (2020)

Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy
por: Pialat, Pierre-Marie, et al.
Publicado: (2021)

Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions
por: Boyce-Fappiano, David, et al.
Publicado: (2022)

Acute toxicity profile in prostate cancer with conventional and hypofractionated treatment
por: Viani, Gustavo Arruda, et al.
Publicado: (2013)

Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer
por: Faria, Sergio L, et al.
Publicado: (2006)

Image Guided Hypofractionated Radiotherapy by Helical Tomotherapy for Prostate Carcinoma: Toxicity and Impact on Nadir PSA
por: Barra, Salvina, et al.
Publicado: (2014)

Cost‐containment in hypofractionated radiation therapy: a literature review
por: Hunter, Darren, et al.
Publicado: (2018)

Hypofractionated radiation in secretory breast cancer: A case report
por: Tatebe, Ken, et al.
Publicado: (2021)

The cost of cancer care is not related to its outcomes
por: Storme, Guy, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sd9qc58dc0o873mkfq0hjav8gl